{"id":"W2551958233","doi":"10.1016/j.jaad.2016.09.026","title":"Short- and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":130,"is_retracted":false,"has_abstract":false,"ca_institutions":"Innovaderm (Canada); Probity Medical Research","funders":"","keywords":"Ixekizumab; Medicine; Etanercept; Psoriasis; Adverse effect; Clinical trial; Incidence (geometry); Internal medicine; Psoriatic arthritis; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02381375,0.001085944,0.004445511,0.001332679,0.000509089,0.002801634,0.0008250515,0.001356538,0.002300472],"category_scores_gemma":[0.01638333,0.0004920873,0.007913013,0.001774185,0.0008309947,0.002821236,0.00140771,0.00239545,0.0004444774],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001026287,"about_ca_system_score_gemma":0.001111094,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004567302,"about_ca_topic_score_gemma":0.000987894,"domain_scores_codex":[0.9824951,0.0079928,0.003697824,0.001916088,0.002984805,0.0009135176],"domain_scores_gemma":[0.9764024,0.01138289,0.006934315,0.0021347,0.002144053,0.001001697],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.5482479,0.001779661,0.1766841,0.006910204,0.1255829,0.0002318928,0.0006383146,0.003789348,0.007450682,0.0004636801,0.002721062,0.1255003],"study_design_scores_gemma":[0.07884353,0.09342911,0.6656814,0.001272885,0.1409998,0.001029607,0.0006726247,0.001852571,0.005602708,0.001445089,0.008895623,0.0002750363],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9328346,0.05510181,0.001747636,0.0004568888,0.0001546222,0.0005688177,0.006481316,0.00005206757,0.002602249],"genre_scores_gemma":[0.9858606,0.00529519,0.0008446447,0.0003334065,0.0001874095,0.0004138248,0.006512627,0.00003753405,0.0005147879],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02381375,"threshold_uncertainty_score":0.1259407,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.112103159361773,"score_gpt":0.3928063394197767,"score_spread":0.2807031800580038,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}